{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:51:38Z","timestamp":1759564298463,"version":"3.37.3"},"reference-count":15,"publisher":"Informa UK Limited","issue":"9","funder":[{"DOI":"10.13039\/100000002","name":"the National Institute of Health","doi-asserted-by":"publisher","award":["R01 ES 028615-01"],"award-info":[{"award-number":["R01 ES 028615-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2018,9,2]]},"DOI":"10.1080\/17425255.2018.1506766","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T09:10:04Z","timestamp":1532941804000},"page":"887-889","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Uterine fibroid therapy: the pharmacokinetic considerations"],"prefix":"10.1080","volume":"14","author":[{"given":"Mohamed","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USA"},{"name":"Clinical Pharmacy department, Faculty of pharmacy, Ain Shams University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"doi-asserted-by":"publisher","key":"CIT0001","DOI":"10.1093\/biolre\/iox094"},{"doi-asserted-by":"publisher","key":"CIT0002","DOI":"10.1186\/1742-4755-11-10"},{"doi-asserted-by":"publisher","key":"CIT0003","DOI":"10.1080\/17460441.2018.1417381"},{"unstructured":"LA. LUPRON DEPOT\u00ae 3.75 mg - Food and Drug administration (FDA) drugs. 2011. [cited 2018 May]. Available from: https:\/\/wwwaccessdatafdagov\/drugsatfda_docs\/label\/2011\/019943s032,020011s039lblpdf.","key":"CIT0004"},{"doi-asserted-by":"publisher","key":"CIT0005","DOI":"10.1002\/14651858.CD010854.pub2"},{"doi-asserted-by":"publisher","key":"CIT0006","DOI":"10.1517\/17425255.2016.1171316"},{"doi-asserted-by":"publisher","key":"CIT0007","DOI":"10.1080\/14728214.2018.1446943"},{"doi-asserted-by":"publisher","key":"CIT0008","DOI":"10.1080\/17425255.2018.1417389"},{"doi-asserted-by":"publisher","key":"CIT0009","DOI":"10.1177\/1933719114549850"},{"doi-asserted-by":"publisher","key":"CIT0010","DOI":"10.1016\/j.fertnstert.2010.09.059"},{"unstructured":"EMA. EMA starts review of Esmya for uterine fibroids; Review triggered by cases of liver injury. 2018. [cited 2018 May]. Available from: http:\/\/wwwemaeuropaeu\/docs\/en_GB\/document_library\/Referrals_document\/Esmya_20\/Procedure_started\/WC500239713pdf","key":"CIT0011"},{"doi-asserted-by":"publisher","key":"CIT0012","DOI":"10.1080\/13543784.2018.1471134"},{"doi-asserted-by":"publisher","key":"CIT0013","DOI":"10.5414\/CP202756"},{"unstructured":"EMA. Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing. 2018. cited 2018 May. Available from: http:\/\/wwwemaeuropaeu\/docs\/en_GB\/document_library\/Press_release\/2018\/02\/WC500243548pdf.","key":"CIT0014"},{"doi-asserted-by":"publisher","key":"CIT0015","DOI":"10.1186\/s13321-015-0053-y"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2018.1506766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T17:21:30Z","timestamp":1599412890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2018.1506766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,2]]}},"alternative-id":["10.1080\/17425255.2018.1506766"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2018.1506766","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"type":"print","value":"1742-5255"},{"type":"electronic","value":"1744-7607"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-05-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}